Cargando…
Differences in Chemotaxis to Fibronectin in Weakly and Highly Metastatic Tumor Cells
We have examined the chemotactic ability of tumor cell lines with different metastatic potential to plasma fibronectin in Transwell chamber assay. Human renal carcinoma cells with highly metastatic potential, SN12 C‐2, chemotactically migrated to fibronectin (10 μg/ml) about three‐fold more strongly...
Autores principales: | Murata, Jun, Saiki, Ikuo, Yonedal, Junya, Azuma, Ichiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
1992
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5918736/ https://www.ncbi.nlm.nih.gov/pubmed/1483947 http://dx.doi.org/10.1111/j.1349-7006.1992.tb02765.x |
Ejemplares similares
-
Inhibitory Effect of Fibronectin and Its Recombinant Polypeptides on the Adhesion of Metastatic Melanoma Cells to Laminin
por: Saiki, Ikuo, et al.
Publicado: (1991) -
Inhibitory Effect of Antimetastatic Fusion Polypeptide of Human Fibronectin on Tumor Cell Adhesion to Extracellular Matrices
por: Matsutnoto, Yoshihiro, et al.
Publicado: (1991) -
Inhibitory Effect of Recombinant Fibronectin Polypeptides on the Adhesion of Liver‐metastatic Lymphoma Cells to Hepatic Sinusoidal Endothelial Cells and Tumor Invasion
por: Yoneda, Junya, et al.
Publicado: (1994) -
Recombinant Fusion Polypeptide with Cell‐ and Heparin‐binding Domains of Fibronectin Inhibits Liver Metastasis of L5178Y‐ML25 Lymphoma Cells
por: Saiki, Ikuo, et al.
Publicado: (1991) -
Antimetastatic Effect by Anti‐adhesion Therapy with Cell‐adhesive Peptide of Fibronectin in Combination with Anticancer Drugs
por: Saiki, Ikuo, et al.
Publicado: (1993)